NCT06105086View on ClinicalTrials.gov

Risk Analysis Interview IVDR 2023

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

February 20, 2024

Study Completion Date

April 28, 2024

Conditions
Risk Variables
Interventions
OTHER

Semi-structured interview

Participants will be asked pre-defined questions and are allowed to elaborate on the subject.

Trial Locations (1)

1090

UZ brussel, Brussels

All Listed Sponsors
collaborator

Vrije Universiteit Brussel

OTHER

lead

Universitair Ziekenhuis Brussel

OTHER

NCT06105086 - Risk Analysis Interview IVDR 2023 | Biotech Hunter | Biotech Hunter